Werba Rubin Papier Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-4,270
Closed -$217K – 288
2025
Q4
$217K Buy
4,270
+241
+6% +$12.3K 0.06% 211
2025
Q3
$224K Sell
4,029
-349
-8% -$20.4K 0.04% 219
2025
Q2
$302K Buy
4,378
+173
+4% +$11.8K 0.06% 157
2025
Q1
$292K Sell
4,205
-365
-8% -$30.1K 0.06% 135
2024
Q4
$393K Sell
4,570
-893
-16% -$96.6K 0.09% 115
2024
Q3
$650K Sell
5,463
-7
-0.1% -$934 0.15% 85
2024
Q2
$781K Buy
5,470
+984
+22% +$130K 0.22% 67
2024
Q1
$580K Buy
4,486
+242
+6% +$28.8K 0.17% 70
2023
Q4
$439K Hold
4,244
– – 0.15% 63
2023
Q3
$386K Hold
4,244
– – 0.14% 71
2023
Q2
$343K Hold
4,244
– – 0.12% 76
2023
Q1
$340K Hold
4,244
– – 0.13% 69
2022
Q4
$287K Buy
+4,244
New +$249K 0.12% 75

Other funds holding NVO

Werba Rubin Papier Wealth Management's NVO Position: Q1 2026 in Review

Werba Rubin Papier Wealth Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 4,270 shares — an estimated $217K sold.

Werba Rubin Papier Wealth Management first reported a position in NVO in Q4 2022 and held it in 13 quarters. The position peaked at $781K in Q2 2024. 1,279 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Werba Rubin Papier Wealth Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Werba Rubin Papier Wealth Management sold 4,270 Novo Nordisk shares in Q1 2026, an estimated $217K.
  • Werba Rubin Papier Wealth Management first reported a position in Novo Nordisk in Q4 2022 and held it in 13 quarters.
  • Werba Rubin Papier Wealth Management's Novo Nordisk position peaked at $781K in Q2 2024.
  • 1,279 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Werba Rubin Papier Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.